PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
This is the continuation of FY06 activity. This activity is related to Track 1 technical assistance activity to the MOH for implementing the national blood transfusion service for prevention of medical transmission of HIV.
The WHO supports a rapid scale up of activities in Ethiopia for the establishment of a sustainable nationally coordinated Blood Transfusion Service. An assessment of existing blood transfusion services to determine their capacity for rapid strengthening of the Blood Transfusion Service infrastructure and program was conducted in COP04. The WHO, assisted by the MOH, developed a five-year strategic plan in collaboration with all key stakeholders for strengthening and restructuring the blood supply system through the regionalization of key services, including testing and processing. The WHO has provided support in training and development of instruments to improve the capacity of blood donor recruitment, blood testing, the clinical interface as well as establishment of quality systems in the national blood supply system. This marked the initiation and part of implementation phase of the program.
In COP06, the WHO continued to provide technical support for implementation of the five-year strategic plan. Assessments of strategies in blood donor recruitment as well as quality systems were done. Roadmaps to address the gaps and strengthen these and other systems have been developed. The roadmaps foresee development, expansion and strengthening of blood bank functions in the next two years.
COP07 WHO will continue to provide assistance to expand and consolidate the blood safety program. The technical assistance will result in the establishment of efficient, sustainable, national blood transfusion services that can assure the quality, safety and adequacy of blood and blood products to meet the needs of all patients requiring transfusion in Ethiopia. This will be achieved through an expanded, stable base of regular voluntary non-remunerated blood donors, cost-effective quality testing and processing and reduce unnecessary transfusions so as to avert adverse transfusion events and reactions. Systems for regular monitoring, evaluation, review and re-planning will be strengthened.
